Steinbach-Rankins JM - Search Results

1

Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections.

Tyo KM, Lasnik AB, Zhang L, Jenson AB, Fuqua JL, Palmer KE, Steinbach-Rankins JM. Tyo KM, et al. Antimicrob Agents Chemother. 2020 May 21;64(6):e02139-19. doi: 10.1128/AAC.02139-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32229493 Free PMC article.

2

Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.

Grooms TN, Vuong HR, Tyo KM, Malik DA, Sims LB, Whittington CP, Palmer KE, Matoba N, Steinbach-Rankins JM. Grooms TN, et al. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6518-6531. doi: 10.1128/AAC.00956-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550363 Free PMC article.

3

Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.

Aniagyei SE, Sims LB, Malik DA, Tyo KM, Curry KC, Kim W, Hodge DA, Duan J, Steinbach-Rankins JM. Aniagyei SE, et al. Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:238-251. doi: 10.1016/j.msec.2016.11.029. Epub 2016 Nov 10. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28024582 Free PMC article.

4

Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.

Tyo KM, Vuong HR, Malik DA, Sims LB, Alatassi H, Duan J, Watson WH, Steinbach-Rankins JM. Tyo KM, et al. Int J Pharm. 2017 Oct 5;531(1):118-133. doi: 10.1016/j.ijpharm.2017.08.061. Epub 2017 Aug 7. Int J Pharm. 2017. PMID: 28797967 Free PMC article.

5

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.

Vuong HR, Tyo KM, Steinbach-Rankins JM. Vuong HR, et al. J Vis Exp. 2017 Oct 31;(128):56492. doi: 10.3791/56492. J Vis Exp. 2017. PMID: 29155732 Free PMC article.

6

Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.

Halwes ME, Tyo KM, Steinbach-Rankins JM, Frieboes HB. Halwes ME, et al. Mol Pharm. 2018 Apr 2;15(4):1534-1547. doi: 10.1021/acs.molpharmaceut.7b01089. Epub 2018 Feb 26. Mol Pharm. 2018. PMID: 29481088

7

pH-responsive delivery of Griffithsin from electrospun fibers.

Tyo KM, Duan J, Kollipara P, Dela Cerna MVC, Lee D, Palmer KE, Steinbach-Rankins JM. Tyo KM, et al. Eur J Pharm Biopharm. 2019 May;138:64-74. doi: 10.1016/j.ejpb.2018.04.013. Epub 2018 Apr 23. Eur J Pharm Biopharm. 2019. PMID: 29698714

8

Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling.

Sims LB, Frieboes HB, Steinbach-Rankins JM. Sims LB, et al. Int J Nanomedicine. 2018 May 3;13:2709-2727. doi: 10.2147/IJN.S160044. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29760551 Free PMC article. Review.

9

Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.

Tyo KM, Minooei F, Curry KC, NeCamp SM, Graves DL, Fried JR, Steinbach-Rankins JM. Tyo KM, et al. Pharmaceutics. 2019 Apr 3;11(4):160. doi: 10.3390/pharmaceutics11040160. Pharmaceutics. 2019. PMID: 30987206 Free PMC article. Review.

10

Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma.

Sims LB, Tyo KM, Stocke S, Mahmoud MY, Ramasubramanian A, Steinbach-Rankins JM. Sims LB, et al. Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1696-1705. doi: 10.1167/iovs.18-26251. Invest Ophthalmol Vis Sci. 2019. PMID: 31009525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters